Hemato Oncology Testing Market by Product & Services (Assay Kits, Services), Cancer (Leukemia (Acute Lymphoblastic, Acute Myeloid), Non-Hodgkin’s Lymphoma), Technology (PCR, NGS, IHC), End-User (Clinical Laboratories, Hospitals) - Global Forecast to 2024

Hemato Oncology Testing Market by Product & Services (Assay Kits, Services), Cancer (Leukemia (Acute Lymphoblastic, Acute Myeloid), Non-Hodgkin’s Lymphoma), Technology (PCR, NGS, IHC), End-User (Clinical Laboratories, Hospitals) - Global Forecast to 2024

“Hemato oncology testing market to register a CAGR of 14.8% from 2019 to 2024”
The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period. Growth in this market is mainly driven by the rising incidences & prevalence of leukemia, increasing collaborations for developing new assay kits, and the growing focus on personalized medicine.

“Services accounted for the larger share of the hemato oncology testing market in 2018”
Based on product & service, the market is segmented into assay kits and services. In 2018, the services segment accounted for a larger share of this market majorly due to the high prevalence of leukemia & lymphoma. The market is set to grow on account of increasing collaborations between hemato oncology testing product manufacturers and pharmaceutical companies.

“Leukemia accounted for the largest share of the hemato oncology testing market in 2018”
Based on cancer type, the hemato oncology testing market has been segmented into three types— leukemia, lymphoma, and other cancers. Leukemia accounted for the largest share in 2018 and is anticipated to witness the highest growth rate during the forecast period due to the need for continuous monitoring of leukemia patients. In addition, increasing awareness about checking the status of minimal residual disease (MRD) in leukemia patients is another factor supporting market growth.

“North America dominates the hemato oncology testing market”
North America, which includes the US and Canada, accounted for the largest share of the hemato oncology testing in 2018. The large share of this market segment can be attributed to the availability of reimbursement for hemato oncology testing products, increasing awareness regarding advanced treatment theories, and the strong presence of industry players in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:
By Company Type: Tier 1: 70% , Tier 2: 20%, and Tier 3: 10%
By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
By Region: North America: 35%, Europe: 24%, Asia: 25%, and the RoW: 16%

The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), QIAGEN N.V. (Germany), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), MolecularMD (Ireland), Invivoscribe, Inc. (US), Asuragen, Inc. (US), Adaptive Biotechnologies (US), ArcherDx, Inc. (US), and ARUP Laboratories Inc. (US).

Research Coverage
This report studies the hemato oncology testing market based on product & service, cancer type, technology, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total hemato oncology testing market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the hemato oncology testing offered by the top 12 players in the market. The report analyzes the hemato oncology testing market by product and region

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hemato oncology testing across key geographic regions

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hemato oncology testing market

Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the hemato oncology testing market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • HEMATO-ONCOLOGY TESTING: MARKET OVERVIEW
    • NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT AND SERVICE (2018)
    • GEOGRAPHICAL SNAPSHOT OF THE HEMATO-ONCOLOGY TESTING MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table HEMATOLOGIC CANCER INCIDENCE, BY TYPE, 2018-2040
        • Table GERIATRIC POPULATION, BY REGION, 2015 VS. 2030
      • OPPORTUNITIES
        • Table HEALTH EXPENDITURE PER CAPITA, BY COUNTRY, 2009 VS. 2016
        • Table INCIDENCE OF HEMATOLOGIC CANCERS, BY COUNTRY, 2018 VS. 2030
      • RESTRAINTS
        • Table REIMBURSEMENT SCENARIO FOR HEMATO-ONCOLOGY TESTING PRODUCTS ACROSS REGIONS
      • CHALLENGES
  • HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
    • SERVICES
      • RISING INCIDENCE OF HEMATOLOGIC CANCER TO INCREASE THE DEMAND FOR HEMATO-ONCOLOGY SERVICES
        • Table HEMATO-ONCOLOGY TESTING SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
        • Table HEMATO-ONCOLOGY TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
    • ASSAY KITS
      • GROWING FOCUS ON THE DEVELOPMENT OF ADVANCED ASSAY KITS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
        • Table HEMATO-ONCOLOGY TESTING ASSAY KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE
    • INTRODUCTION
      • Table HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
    • LEUKEMIA
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY REGION, 2017-2024 (USD MILLION)
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
      • ACUTE MYELOID LEUKEMIA
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR ACUTE MYELOID LEUKEMIA, BY REGION, 2017-2024 (USD MILLION)
      • ACUTE LYMPHOCYTIC LEUKEMIA
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR ACUTE LYMPHOCYTIC LEUKEMIA, BY REGION, 2017-2024 (USD MILLION)
      • OTHER LEUKEMIAS
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR OTHER LEUKEMIAS, BY REGION, 2017-2024 (USD MILLION)
    • LYMPHOMA
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY REGION, 2017-2024 (USD MILLION)
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
      • NON-HODGKIN LYMPHOMA
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR NON-HODGKIN LYMPHOMA, BY REGION, 2017-2024 (USD MILLION)
      • HODGKIN LYMPHOMA
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR HODGKIN LYMPHOMA, BY REGION, 2017-2024 (USD MILLION)
    • OTHER CANCERS
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR OTHER CANCERS, BY REGION, 2017-2024 (USD MILLION)
  • HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
    • PCR
      • PCR ACCOUNTED FOR THE LARGEST SHARE OF THE HEMATOONCOLOGY TESTING MARKET IN 2018
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR PCR, BY REGION, 2017-2024 (USD MILLION)
    • IHC
      • IHC ACCOUNTED FOR THE SECOND-LARGEST SHARE OF THE HEMATO-ONCOLOGY TESTING MARKET
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR IHC, BY REGION, 2017-2024 (USD MILLION)
    • NGS
      • NGS IS EXPECTED TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR NGS, BY REGION, 2017-2024 (USD MILLION)
    • CYTOGENETICS
      • NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE CYTOGENETICS MARKET
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR CYTOGENETICS, BY REGION, 2017-2024 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2017-2024 (USD MILLION)
  • HEMATO-ONCOLOGY TESTING MARKET, BY END USER
    • INTRODUCTION
      • Table HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • CLINICAL LABORATORIES
      • PRESENCE OF ROBUST INFRASTRUCTURE IS THE MAJOR DRIVING FACTOR FOR THIS SEGMENT
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR REFERENCE LABORATORIES, BY REGION, 2017-2024 (USD MILLION)
    • HOSPITALS
      • HOSPITALS ACCOUNTED FOR THE SECOND-LARGEST SHARE OF THE MARKET, BY END USER
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR HOSPITALS, BY REGION, 2017-2024 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • APAC MARKET FOR ACADEMIC & RESEARCH INSTITUTES WILL GROW AT THE HIGHEST RATE
        • Table HEMATO-ONCOLOGY TESTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
    • OTHER END USERS
      • Table HEMATO-ONCOLOGY TESTING MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • HEMATO-ONCOLOGY TESTING MARKET, BY REGION
    • INTRODUCTION
      • Table HEMATO-ONCOLOGY TESTING MARKET, BY REGION, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • US
        • Table US: LEUKEMIA AT A GLANCE
        • Table US: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table US: HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
        • Table US: HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table US: HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
      • CANADA
        • Table CANADA: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table CANADA: HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table CANADA: HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • EUROPE
      • RISING FOCUS ON BIOMARKER DEVELOPMENT IN EU COUNTRIES TO SUPPORT MARKET GROWTH
        • Table INCIDENCE OF LEUKEMIA, BY COUNTRY, 2018-2035
        • Table EUROPE: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table EUROPE: HEMATO-ONCOLOGY TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table EUROPE: HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
        • Table EUROPE: HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
        • Table EUROPE: HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
        • Table EUROPE: HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table EUROPE: HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • ASIA PACIFIC
      • ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
        • Table GERIATRIC POPULATION, BY COUNTRY, 2015 VS. 2030
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
        • Table ASIA PACIFIC: HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: HEMATO-ONCOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
      • Table ROW: HEMATO-ONCOLOGY TESTING SERVICES MARKET, BY TYPE, 2017-2024 (USD MILLION)
      • Table ROW: HEMATO-ONCOLOGY TESTING MARKET, BY CANCER TYPE, 2017-2024 (USD MILLION)
      • Table ROW: HEMATO-ONCOLOGY TESTING MARKET FOR LEUKEMIA, BY TYPE, 2017-2024 (USD MILLION)
      • Table ROW: HEMATO-ONCOLOGY TESTING MARKET FOR LYMPHOMA, BY TYPE, 2017-2024 (USD MILLION)
      • Table ROW: HEMATO-ONCOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION)
      • Table ROW: HEMATO-ONCOLOGY TESTING MARKET, BY END USER, 2017-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING ANALYSIS, 2017
      • Table RANKING OF COMPANIES IN THE HEMATO-ONCOLOGY TESTING MARKET, 2018
    • KEY STRATEGIES
      • PRODUCT LAUNCHES & APPROVALS, 2016-2019
      • EXPANSIONS, 2016-2019
      • PARTNERSHIPS AND COLLABORATIONS, 2016-2019
      • ACQUISITIONS, 2016-2019
  • COMPANY PROFILES
    • F. HOFFMAN-LA ROCHE LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016-2019)
      • MNM VIEW
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MOLECULARMD (SUBSIDIARY OF ICON PLC)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016-2019)
      • MNM VIEW
    • ARCHERDX, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ARUP LABORATORIES INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • MNM VIEW
    • ASURAGEN, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016-2019)
      • MNM VIEW
    • INVIVOSCRIBE, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016-2019)
      • MNM VIEW
    • ADAPTIVE BIOTECHNOLOGIES.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS (2016-2019)
      • MNM VIEW
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook